Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
IBRN vs ISCG
Shared holdings
14
IBRN covered by ISCG
11.84%
ISCG covered by IBRN
11.84%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
IBRN (Jan. 31, 2026)
| Security | Weight | |
|---|---|---|
| BlackRock Cash Funds: Institutional, SL Agency Shares | 11.74% | |
| PRAXIS PRECISION MEDICINES INC | 4.43% | |
| AXSOME THERAPEUTICS INC | 4.32% | |
| ALKERMES PLC | 4.02% | |
| BIOGEN INC | 3.47% | |
| SCHOLAR ROCK HOLDING CORP | 3.45% | |
| PTC THERAPEUTICS INC | 3.42% | |
| DENALI THERAPEUTICS INC | 3.27% | |
| ARGENX SE SPONSORED ADR | 3.26% | |
| ACADIA PHARMACEUTICALS INC | 3.20% | |
| XENON PHARMACEUTICALS INC | 3.19% | |
| CATALYST PHARMACEUTICALS INC | 3.12% | |
| NEUROCRINE BIOSCIENCES INC | 3.06% | |
| SUPERNUS PHARMACEUTICALS INC | 3.04% | |
| CENTESSA PHARMACEUTICALS LTD ADR | 2.73% | |
| SK BIOPHARMS. CO LTD | 2.65% | |
| EDGEWISE THERAPEUTICS INC | 2.49% | |
| AVADEL PHARMACEU | 2.33% | |
| SAREPTA THERAPEUTICS INC | 2.33% | |
| DYNE THERAPEUTICS INC | 2.17% | |
| DIANTHUS THERAPEUTICS INC | 2.17% | |
| H LUNDBECK A/S | 2.08% | |
| AXOGEN INC | 1.81% | |
| BIOARCTIC AB | 1.61% | |
| BIOHAVEN LTD | 1.48% | |
| NEUREN PHARMACEU | 1.45% | |
| TAYSHA GENE THERAPIES INC | 1.17% | |
| TOBII DYNAVOX AB | 1.10% | |
| CAPRICOR THERAPEUTICS INC | 1.02% | |
| IDORSIA LTD | 0.91% | |
| ANNEXON INC | 0.89% | |
| RAPPORT THERAPEUTICS INC | 0.87% | |
| INTEGRA LIFESCIENCES HLDS CORP | 0.85% | |
| SANBIO CO LTD | 0.80% | |
| ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO LTD | 0.71% | |
| Bright Minds Biosciences Inc COM NEW | 0.70% | |
| MEDINCELL SA | 0.64% | |
| FULCRUM THERAPEUTICS INC | 0.60% | |
| REGENXBIO INC | 0.60% | |
| MICROPORT NEUROTECH LTD | 0.54% | |
| CERIBELL INC | 0.53% | |
| ANAVEX LIFE SCIENCES CORP | 0.49% | |
| VANDA PHARMACEUTICALS INC | 0.48% | |
| BENITEC BIOPHARMA INC | 0.46% | |
| NEUROPACE INC | 0.45% | |
| PEIJIA MEDICAL LTD | 0.44% | |
| PROTHENA CORP PLC COMMON STOCK USD.01 | 0.44% | |
| SOLID BIOSCIENCES INC | 0.43% | |
| ONCOLYS BIOPHARMA INC | 0.37% | |
| CLEARPOINT NEURO INC | 0.36% |
ISCG (Jan. 31, 2026)
| Security | Weight | |
|---|---|---|
| BlackRock Cash Funds: Institutional, SL Agency Shares | 10.53% | |
| LUMENTUM HOLDINGS INC | 0.84% | |
| KRATOS DEFENSE and SEC SOLTN INC | 0.53% | |
| ATI INC | 0.50% | |
| ITT INC | 0.49% | |
| RBC BEARINGS INC | 0.48% | |
| MUELLER INDUSTRIES INC | 0.47% | |
| LINCOLN ELECTRIC HLDGS INC | 0.46% | |
| NORDSON CORP | 0.45% | |
| MACOM TECHNOLOGY SOLUTIONS HOLDINGS INC | 0.43% | |
| NEUROCRINE BIOSCIENCES INC | 0.42% | |
| PENUMBRA INC | 0.42% | |
| CLEAN HARBORS INC | 0.41% | |
| GUARDANT HEALTH INC | 0.41% | |
| EVERCORE INC A | 0.41% | |
| QXO INC | 0.41% | |
| DOMINOS PIZZA INC | 0.41% | |
| API GROUP CORP | 0.40% | |
| EXACT SCIENCES CORP | 0.39% | |
| IONIS PHARMACEUTICALS INC | 0.38% | |
| RAMBUS INC | 0.38% | |
| ROKU INC CLASS A | 0.38% | |
| TEXAS ROADHOUSE INC | 0.37% | |
| TRADEWEB MARKETS INC A | 0.37% | |
| NEW YORK TIMES CO CL A | 0.36% | |
| LATTICE SEMICONDUCTOR CORP | 0.35% | |
| STERLING INFRASTRUCTURE INC | 0.34% | |
| BRIDGEBIO PHARMA INC | 0.34% | |
| DAYFORCE INC | 0.34% | |
| NEXTRACKER INC CL A | 0.33% | |
| ADVANCED DRAINAGE SYSTEMS INC | 0.33% | |
| GLOBUS MEDICAL INC | 0.33% | |
| FIVE BELOW INC | 0.32% | |
| HUNTINGTON INGALLS INDUSTRIES INC | 0.32% | |
| SPX TECHNOLOGIES INC | 0.32% | |
| DYCOM INDUSTRIES INC | 0.32% | |
| APPLIED INDU TEC | 0.31% | |
| GENERAC HOLDINGS INC | 0.31% | |
| ONTO INNOVATION INC | 0.31% | |
| ENSIGN GROUP INC | 0.31% | |
| REVOLUTION MEDICINES INC | 0.30% | |
| ADV ENERGY INDS | 0.30% | |
| EASTGROUP PROP | 0.30% | |
| TETRA TECH INC | 0.29% | |
| CHART INDUSTRIES INC | 0.29% | |
| JONES LANG LASALLE INC | 0.29% | |
| TTM TECHNOLOGIES INC | 0.29% | |
| HOULIHAN LOKEY I | 0.29% | |
| MANHATTAN ASSOCIATES INC | 0.29% | |
| MODINE MFG CO | 0.29% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.